Proteomic: New advances in the diagnosis of rheumatoid arthritis
- 1 July 2005
- journal article
- review article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 357 (2) , 219-225
- https://doi.org/10.1016/j.cccn.2005.03.030
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Anti-cyclic citrullinated peptide autoantibodies measured by an automated enzyme immunoassay: Analytical performance and clinical correlationsClinica Chimica Acta; International Journal of Clinical Chemistry, 2005
- The benefits of early treatment in rheumatoid arthritis: Confounding by indication, and the issue of timingArthritis & Rheumatism, 2003
- Influence of disease‐modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: Results from a large observational inception studyArthritis & Rheumatism, 2003
- Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.Journal of Clinical Investigation, 1998
- Autoimmune response to the spliceosomeArthritis & Rheumatism, 1995
- Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study.Annals of the Rheumatic Diseases, 1992
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Seronegative rheumatoid arthritis.Arthritis & Rheumatism, 1982
- Anti-keratin antibodies in rheumatoid arthritis.BMJ, 1979
- New Serum Factor in Patients with Rheumatoid Arthritis: The Antiperinuclear FactorAnnals of the Rheumatic Diseases, 1964